JY
AIM

Jeff Yass’s AIM ImmunoTech AIM Stock Holding History

Jeff Yass’s Portfolio AIM Stock Details AIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.21K Buy
+21,859
New +$9.99K ﹤0.01% 13174
2025
Q1 		– Sell
-381
Closed -$7.53K – 13841
2024
Q4 		$7.53K Buy
+381
New +$8.88K ﹤0.01% 11996
2024
Q2 		– Sell
-168
Closed -$7.93K – 13638
2024
Q1 		$7.93K Buy
168
+16
+11% +$663 ﹤0.01% 11927
2023
Q4 		$6.69K Buy
+152
New +$7.09K ﹤0.01% 12109
2023
Q3 		– Sell
-547
Closed -$36.6K – 13532
2023
Q2 		$36.6K Buy
547
+447
+447% +$21.6K ﹤0.01% 11454
2023
Q1 		$4.3K Sell
100
-241
-71% -$12.5K ﹤0.01% 12321
2022
Q4 		$10.6K Buy
341
+51
+18% +$2.37K ﹤0.01% 11931
2022
Q3 		$17K Buy
290
+99
+52% +$6.93K ﹤0.01% 12665
2022
Q2 		$15K Buy
+191
New +$18.3K ﹤0.01% 12435
2022
Q1 		– Sell
-378
Closed -$35K – 14705
2021
Q4 		$35K Buy
378
+16
+4% +$2.47K ﹤0.01% 12706
2021
Q3 		$73K Buy
+362
New +$73.1K ﹤0.01% 12211
2020
Q3 		– Sell
-253
Closed -$63K – 11604
2020
Q2 		$63K Buy
+253
New +$61.4K ﹤0.01% 9692
2019
Q1 		– Sell
-14
Closed -$11K – 10685
2018
Q4 		$11K Buy
14
+9
+180% +$8.26K ﹤0.01% 8744
2018
Q3 		$6K Buy
+5
New +$6.1K ﹤0.01% 9061
2018
Q1 		– Sell
-12
Closed -$18K – 10979
2017
Q4 		$18K Buy
12
+1
+9% +$1.44K ﹤0.01% 9082
2017
Q3 		$16K Buy
+11
New +$19.3K ﹤0.01% 8670
2017
Q2 		– Sell
-9
Closed -$22K – 10525
2017
Q1 		$22K Sell
9
-4
-31% -$10.2K ﹤0.01% 8723
2016
Q4 		$39K Buy
+13
New +$52.4K ﹤0.01% 9346
2016
Q2 		– Sell
-2
Closed -$12K – 10178
2016
Q1 		$12K Buy
+2
New +$12.8K ﹤0.01% 8872

Other funds holding AIM

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
CA
Continuum Advisory Eagle, Idaho $1.24B AUM 30.12% 1-Year Est. Return

Jeff Yass's AIM Position: Q2 2026 in Review

Jeff Yass opened a new position in AIM ImmunoTech (AIM) in Q2 2026: 21,859 shares worth $6.21K. The stake represents ﹤0.01% of the portfolio and ranks #13174 among its holdings. This is a return to the name: Jeff Yass previously reported a position in AIM as recently as Q4 2024.

Jeff Yass first reported a position in AIM in Q1 2016 and has held it in 19 quarters since. The position peaked at $73K in Q3 2021. 18 funds tracked by Wall St. Rank hold AIM as of Q2 2026.

  • Jeff Yass held 21,859 shares of AIM ImmunoTech worth $6.21K as of Q2 2026.
  • AIM ImmunoTech was a new Jeff Yass position in Q2 2026.
  • AIM ImmunoTech made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #13174 holding.
  • Jeff Yass first reported a position in AIM ImmunoTech in Q1 2016 and has held it in 19 quarters since.
  • Jeff Yass's AIM ImmunoTech position peaked at $73K in Q3 2021.
  • 18 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.